- Home
- VIR vs PTA Comparison
VIR vs PTA Comparison
Compare VIR & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- PTA
- Stock Information
- Founded
- VIR 2016
- PTA 2020
- Country
- VIR United States
- PTA United States
- Employees
- VIR N/A
- PTA N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- PTA Trusts Except Educational Religious and Charitable
- Sector
- VIR Health Care
- PTA Finance
- Exchange
- VIR Nasdaq
- PTA Nasdaq
- Market Cap
- VIR 1.0B
- PTA 1.1B
- IPO Year
- VIR 2019
- PTA N/A
- Fundamental
- Price
- VIR $7.47
- PTA $19.10
- Analyst Decision
- VIR Buy
- PTA
- Analyst Count
- VIR 5
- PTA 0
- Target Price
- VIR $36.40
- PTA N/A
- AVG Volume (30 Days)
- VIR 1.4M
- PTA 159.2K
- Earning Date
- VIR 02-20-2025
- PTA 01-01-0001
- Dividend Yield
- VIR N/A
- PTA 8.31%
- EPS Growth
- VIR N/A
- PTA N/A
- EPS
- VIR N/A
- PTA N/A
- Revenue
- VIR $78,618,000.00
- PTA N/A
- Revenue This Year
- VIR N/A
- PTA N/A
- Revenue Next Year
- VIR N/A
- PTA N/A
- P/E Ratio
- VIR N/A
- PTA N/A
- Revenue Growth
- VIR N/A
- PTA N/A
- 52 Week Low
- VIR $6.56
- PTA $15.84
- 52 Week High
- VIR $13.09
- PTA $19.67
- Technical
- Relative Strength Index (RSI)
- VIR 45.87
- PTA 32.04
- Support Level
- VIR $7.15
- PTA $19.11
- Resistance Level
- VIR $7.56
- PTA $19.35
- Average True Range (ATR)
- VIR 0.40
- PTA 0.25
- MACD
- VIR -0.02
- PTA -0.05
- Stochastic Oscillator
- VIR 24.79
- PTA 20.00
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.